Education
About Us
Working with TipRanks
Follow Us
DermTech (DMTKQ)
OTHER OTC:DMTKQ
Total Valuation
DermTech has a market cap or net worth of $35.00. The enterprise value is ―.
Market Cap$35.00
Enterprise Value―
Share Statistics
DermTech has 35,253,582 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,253,582
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
DermTech’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee74.25K
Profits Per Employee-489.75K
Employee Count206
Asset Turnover0.13
Inventory Turnover14.96
Valuation Ratios
The current PE Ratio of DermTech is -0.54. DermTech’s PEG ratio is >-0.01.
PE Ratio-0.54
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value0.95
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, DermTech had revenue of 15.30M and earned -100.89M in profits. Earnings per share was -3.09.
Revenue15.30M
Gross Profit276.00K
Operating Income-103.74M
Pretax Income-100.89M
Net Income-100.89M
EBITDA-97.89M
Earnings Per Share (EPS)-3.09
Cash Flow
In the last 12 months, operating cash flow was -72.07M and capital expenditures -145.00K, giving a free cash flow of -72.22M billion.
Operating Cash Flow-72.07M
Free Cash Flow-72.22M
Free Cash Flow per Share-2.05
Dividends & Yields
DermTech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-48.14
52-Week Price Change-94.29%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)102.77K
Important Dates
DermTech upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
DermTech as a current ratio of 4.59, with Debt / Equity ratio of 134.19%
Current Ratio4.59
Quick Ratio4.52
Debt to Market Cap0.05
Net Debt to EBITDA―
Interest Coverage Ratio0.00
Taxes
In the past 12 months, DermTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
DermTech EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
DermTech has $38.98M in cash and marketable securities with $53.67M in debt, giving a net cash position of $14.69M billion.
Cash & Marketable Securities$38.98M
Total Debt$53.67M
Net Cash$14.69M
Net Cash Per Share$0.42
Tangible Book Value Per Share$1.75
Margins
Gross margin is 11.34%, with operating margin of -678.21%, and net profit margin of -659.57%.
Gross Margin11.34%
Operating Margin-678.21%
Pretax Margin-659.57%
Net Profit Margin-659.57%
EBITDA Margin-639.99%
EBIT Margin-678.21%
Analyst Forecast
The average price target for DermTech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.71%
EPS Growth Forecast31.13%